Actemra (tocilizumab) Product Information (PI) - Roche Australia
Actemra (tocilizumab) Product Information (PI) - Roche Australia
Actemra (tocilizumab) Product Information (PI) - Roche Australia
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Rheumatoid Arthritis<br />
From a 100 mL infusion bag, withdraw a volume of 0.9% sodium chloride solution equal<br />
to the volume of the ACTEMRA solution required for the patient’s dose, and discard.<br />
Withdraw the required amount of ACTEMRA (0.4 mL per kg of the patient’s body<br />
weight) under aseptic conditions and add to the infusion bag. To mix the solution, gently<br />
invert the bag to avoid foaming.<br />
pJIA and sJIA patients ≥ 30 kg<br />
From a 100 mL infusion bag, withdraw a volume of 0.9% sodium chloride solution equal<br />
to the volume of the ACTEMRA solution required for the patient’s dose. Withdraw the<br />
required amount of ACTEMRA (0.4 mL per kg of the patient’s body weight) under<br />
aseptic conditions and dilute in a 100 mL infusion bag containing sterile, non-pyrogenic<br />
0.9% sodium chloride solution. To mix the solution, gently invert the bag to avoid<br />
foaming.<br />
pJIA patients < 30 kg<br />
From a 50 mL infusion bag, withdraw a volume of 0.9% sodium chloride solution equal<br />
to 0.5 mL/kg of the patient’s body weight and discard. This volume should be replaced in<br />
the saline bag with an equal volume of ACTEMRA under aseptic conditions. To mix the<br />
solution, gently invert the bag to avoid foaming.<br />
sJIA patients < 30 kg<br />
From a 50 mL infusion bag, withdraw a volume of 0.9% sodium chloride solution equal<br />
to 0.6 mL/kg of the patient’s body weight and discard. This volume should be replaced in<br />
the saline bag with an equal volume of ACTEMRA under aseptic conditions. To mix the<br />
solution, gently invert the bag to avoid foaming.<br />
OVERDOSAGE<br />
There are limited data available on overdosage with ACTEMRA. One case of accidental<br />
overdose was reported in which a patient with multiple myeloma received a single dose<br />
of 40 mg/kg. No adverse drug reactions were observed. No serious adverse drug reactions<br />
were observed in healthy volunteers who received a single dose up to 28 mg/kg, although<br />
dose-limiting neutropenia was observed.<br />
Treatment of overdose should consist of general supportive measures.<br />
Contact the Poisons <strong>Information</strong> Centre for advice on management of overdosage.<br />
PRESENTATION AND STORAGE<br />
ACTEMRA is available as:<br />
*(not marketed)<br />
<strong>Actemra</strong> ® <strong>PI</strong> 131004 35 of 37<br />
CDS 8.0